GENE MODIFIED CELLS

Brand Owner Address Description
FABROGEN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 Gene modified cells for the treatment of Fabry Disease;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention comprises a method for producing mammalian therapeutics free from prion contamination and cells for use in such methods. Such therapeutics are produced in somatic cells having a genome with an artificially altered PrP gene. The PrP gene in these cells may be ablated, or replaced by an exogenous inducible form of the PrP gene. The endogenous gene in the host cells may be disrupted, or disrupted and replaced by an exogenous PrP gene.